In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Takeda Oncology

Teresa Bitetti

The Translational Research and Development team at Takeda Oncology focuses on bridging the gap between laboratory research and clinical application by advancing innovative cancer therapies from preclinical studies to clinical trials. They leverage cutting-edge scientific methods and collaborative strategies to develop personalized treatment approaches, ensuring that novel therapies effectively address patient needs. This team plays a crucial role in optimizing drug development and driving the company’s mission to improve cancer care globally.

Translational Research and Development

About

Team members

Other teams at Takeda Oncology

Oncology Patient Access and Value

Commercial and Regulatory Affairs